1 2 3 4 5 6
читать далее ... 03 24 28-66 8 ACC/AHA Guidelines for the Management of Patients With ST-Bevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) www ace org 9 Ambrosiom E, Borghi С , Magnani В et al The effect of angiotensin-converting enzyme inhibitor zofenopnl on mortality and morbidity after anterior myocardial infarction N EngI J Med 1995 332 80-85 10 Borghi С , Ambrosioni E on behalf of the SMILE-2 Working Party Double-blind comparison between zofenopnl and lisinopnl in patients with acute myocardial infarction Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study Am Heart J 2003 145 80-87 11 Rather M D Yusuf S , Kober L et al Long-term ACE-inhibitor therapy in patients with heart failure or left-ventncular dysfunction a systematic overview of data from individual patients Lancet 2000,355 1575-1581 12 Pfeffer M A, Braunwald E, Moy L, et al Effect of captopnl on mortality and morbidity in patients with left ventncular dysfunction after myocardial infarction results of the survival and ventncular enlargement trial N EngI J Med 1992,327 669-677 13 Acute Infarction Ramipnl Efficacy (AIRE) Study Investigators Effect of ramipnl on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 1993,342 821-828 14 Kober L, Torp-Pedersen С, Carlsen 3 E et al A clinical trial of the angiotensm-converting-enzyme inhibitor trandolapnl in patients with left ventncular dysfunction after myocardial infarction N EngI J Med 1995 333 1670-1676 15 The SOLVD Investigators Effect of enalapnl on survival in patients with reduced left ventncular ejection fractions and congestive heart failure N EngI J Med 1991, 325 293-302 16 The SOLVD Investigators Effect of enalapnl on mortality and the development of heart failure in asymptomatic patients with reduced left ventncular ejection fractions N EngI J Med 1992, 327 685-91 17 Dagenais G R , Yusuf S , Bourassa M G et al Effects of Ramipnl on Coronary Events in High-Risk Persons Results of the Heart Outcomes Prevention Evaluation Study Circulation 2001, 104 522-526 18 The EURopean trial On reduction of cardiac events with Penndopnl in stable coronary Artery disease Investigators Efficacy of penndopnl in reduction of cardiovascular events among patients with stable coronary artery disease randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 2003, 362 782-788Источник: Явелов И.С. Русский медицинский журнал. 2006. Т.14. №10. С.757-760